Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Market Dominance | Ardent Health Partners leads in fast-growing healthcare markets with a $5.7B revenue and differentiated hospital platform, poised for strategic expansion |
Growth Trajectory | Explore ARDT's multifaceted growth strategy, focusing on market expansion, outpatient services, and innovative joint ventures to drive scale and efficiency |
Financial Robustness | Delve into ARDT's strong financials, including a 56.55% gross profit margin and $418.8M EBITDA, with analysts setting a $23 price target, indicating significant upside |
Margin Enhancement | Learn how supplemental Medicaid programs, scale efficiencies, and service line optimization position ARDT for potential margin expansion in a evolving healthcare landscape |
Metrics to compare | ARDT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARDTPeersSector | |
---|---|---|---|---|
P/E Ratio | 6.4x | 1.0x | −0.5x | |
PEG Ratio | 0.01 | 0.16 | 0.00 | |
Price/Book | 1.3x | 0.8x | 2.6x | |
Price / LTM Sales | 0.3x | 1.1x | 3.3x | |
Upside (Analyst Target) | 85.8% | 46.9% | 43.4% | |
Fair Value Upside | Unlock | 20.3% | 7.1% | Unlock |